While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Hosted on MSN
3 biotech stocks that could double in 2026
The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...
However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help ...
In this article, we will be taking a look at the 20 Best Biotech Stocks Under $20 to Buy Now. The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of ...
Investor's Business Daily on MSN
Catalyst Pharmaceuticals joins elite list of stocks with 95-plus composite rating
Catalyst Pharmaceuticals saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.
The tenth stock on our list is Legend Biotech Corporation (NASDAQ:LEGN). TheFly reported on January 22 that H.C. Wainwright lowered LEGN’s price target to $50 from $60 but kept a Buy rating, noting Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results